|Articles|May 1, 1997

May 1997
Volume 3
Issue 5

Economic Winners and Losers After Introduction of an Effective New Therapy Depend on the Type of Payment System

Author(s)William S. Weintraub, MD, Christi D. Warner, PhD, Patrick D. Mauldin, PhD

Download PDF: Economic Winners and Losers After Introduction of an Effective New Therapy Depend on the Type of Payment System

Articles in this issue

about 29 years ago

Article

Clinical Considerations in GERD Therapy: Focus on Cisapride

about 29 years ago

Article

Improving the Quality of the NCQA Annual Member Health Care Survey Version 1.0

about 29 years ago

Article

The Diagnostic and Treatment Approach to Two Common Conditions by the Physician Members of a Community Health Maintenance Organization

about 29 years ago

Article

Health Outcomes and Managed Care: Discussing the Hidden Issues

about 29 years ago

Article

Resource Utilization and Work or School Loss Reported by Patients with Diabetes: Experience in Diabetes Training Programs

about 29 years ago

Article

Diagnosis and Treatment of Chronic Renal Failure in Children

about 29 years ago

Article

Competency, Board Certification, Credentialing, and Specialization: Who Benefits?

about 29 years ago

Article

Correspondence regarding, "Appropriate and Necessary Healthcare: New Language for a New Era"

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Economic Winners and Losers After Introduction of an Effective New Therapy Depend on the Type of Payment System

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

Semaglutide More Than Doubled Likelihood of MASH Resolution

Once-Daily Pill Zasocitinib Clears Psoriasis at Toughest Sites

Everyday Discrimination Linked to Health Care Access Barriers, Lower Preventive Care

Early Remdesivir May Protect Kidney Transplants After COVID-19: Nitipong Permpalung, MD, MPH

Precision Therapies Are Advancing Fast, and Care Delivery Has to Catch Up